PCBP2 and prostate adenocarcinoma: The expression levels of the candidate genes (HNRNPL, ELAVL1, PCBP1, PCBP2, PABPN1, PTPRF, MRPL24, DANCR, MYC, and TRPM4) were validated between tumour and normal tissue samples in TCGA-PRAD dataset.